Mupirocin has been approved in the United States and in the European Union and in the Other Countries

Studies listed may include approved and non-approved uses, formulations or treatment regimens. Before prescribing any product mentioned in this Register, healthcare Professionals should consult prescribing information approved in their country (view UK and US information for Healthcare Professionals).

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.


mupirocin studies

Select the study ID number to view the trial summary

Study IDPhaseTitle
164 II A double blind, randomized, placebo controlled trial to assess the efficacy of mupirocin in eradicating the nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and/or Moraxella catarrhalis.
177 II A single blind study to determine the extent of subject preference for Bactrobanâ cream over a range of creams and ointments.
162 I A randomised, double-blind, placebo-controlled, 21-day repeat dose parallel group study to assess the irritancy of intranasal administration of BRL 4910F mupirocin 5% nasal spray in healthy volunteers.